Treating Acute Leukemias: Blood Cancer United-NMDP Project ECHO series
Live, interactive webinar series for hematology/oncology professionals
The Project ECHO model is designed to create a shared learning space for health care professionals through a series of three educational sessions, fostering peer engagement and disseminating best practices in community care. Rapid advances in the treatment of acute leukemias, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), can make treatment decisions challenging. This virtual series will help providers stay up to date on the latest in disease-specific indications, treatment with hematopoietic cell transplant (HCT) and cell therapy, and post-treatment monitoring and care coordination to improve patient outcomes. Free CME/CE is available.
For each session you participate in, 1.0 credit/contact hour will be provided, for a total of 3.0 possible credits. Participation at all three sessions is encouraged but not required to obtain CME/CE credits.
Target audience
This activity is intended for hematology/oncology providers, including physicians, advanced practice professionals and nurses who want to learn more about managing, treating and monitoring patients with acute leukemias including those undergoing transplant and cell therapy.
Faculty
Alison Loren, MD, MSCE (chair/moderator)
Chief, Division of Hematology/Oncology
Director, Blood and Marrow Transplantation
C. Willard Robinson Professor of Hematology/Oncology
University of Pennsylvania
Philadelphia, Pa.
Shernan Holtan, MD (chair/moderator)
Chief, Blood and Marrow Transplantation Section
Department of Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, N.Y.
Session 1
Alice S. Mims, MD, MSCR
Acute Leukemia Research Section Head
Associate Division Director Clinical Research
Professor of Medicine
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Courtney Bellomo, MD
Hematology
New York Oncology Hematology
Albany, N.Y.
Meghan McGrath, MSN, RN, AGACNP-BC
Clinical Trial Nurse Navigator
Blood Cancer United
Washington, D.C.
Session 2
Faculty to be announced
Session 3
Faculty to be announced
Continuing Education Information
In support of improving patient care, this activity has been planned and implemented by Blood Cancer United, NMDP, and Medical Learning Institute Inc. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registered Nursing Designation
Approval for nurses has been obtained by the National Office of The Blood Cancer United under Provider Number CEP 5832 to award 1.0 continuing education contact hours through the California Board of Registered Nursing.
Providers
This activity is provided by The Blood Cancer United, NMDP and Medical Learning Institute Inc.
There is no commercial support for this activity.
This continuing education activity is provided free of charge.